Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 September 2005

Effective dose of 5-fluorouracil for myringotomy in rats.

Hakan Cincik, Hakan Cincik, Omer Saglam, Engin Cekin, Sükrü Yildirim, Ethem Poyrazoglu

Med Sci Monit 2005; 11(9): BR330-334 :: ID: 428444

Abstract

Background: The purpose of this study is to compare the effects of twodifferent doses of 5-fluorouracil (5-FU) on closure rates and histopathological findings in myringotomyto those of simple myringotomy with saline application. Material/Methods: 36 rats were divided into twostudy groups and a control group of 12 rats each. After bilateral myringotomy, we applied 5-FU 50 mg/mlin group A, 10 mg/ml in group B and saline in the control group for 10 minutes. Examination was madeby otoendoscopy on days 1, 3, 5, 7, 10, 15, 20, 25. After the follow up examination, two rats from eachgroup were randomly sacrificed on days 7, 15, 25 and 35. Both tympanic membranes were investigated forfibrosis and inflammation by light microscopy. Results: Most of the tympanic membranes from group B andthe control group healed on the 10(th) day, but 16 myringotomies were patent in group A; by the 25(th)day, all myringotomies in all three groups were completely healed. The mean healing time was 14.62 days,10.20 days and 10.40 days respectively in groups A, B and control. Fibrosis and inflammation were lessin group A than in group B and the controls. Conclusions: 5-FU at a concentration of 50 mg/mL is effectivein prolonging the patency of myringotomies in rat tympanic membranes, while a concentration of 10 mg/mLhas no greater effect than a simple myringotomy procedure with saline application.

Keywords: Antimetabolites - administration & dosage, Dose-Response Relationship, Drug, Fibrosis, Fluorouracil - administration & dosage, Inflammation - prevention & control, Middle Ear Ventilation - methods, Otitis Media with Effusion - surgery, Tympanic Membrane - surgery, Wound Healing - drug effects

Add Comment 0 Comments

Editorial

01 June 2024 : Editorial  

Editorial: Concerns as Highly Pathogenic Avian Influenza (HPAI) Virus of the H5N1 Subtype is Identified in Dairy Cows and Other Mammals

Dinah V. Parums

DOI: 10.12659/MSM.945315

Med Sci Monit 2024; 30:e945315

0:00

In Press

Clinical Research  

Trust and Support for Cancer Research Biobanks: Insights from Cancer Patients in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.944263  

Clinical Research  

Morphological and Dimensional Analysis of the Nasopalatine Canal: Insights from Cone-Beam Computed Tomograp...

Med Sci Monit In Press; DOI: 10.12659/MSM.944424  

Clinical Research  

Hemorrhagic Cysts in the Pancreas: Risk Factors, Treatment, and Outcomes – Insights from a Single-Center Study

Med Sci Monit In Press; DOI: 10.12659/MSM.941955  

Clinical Research  

Perioperative Administration of Tranexamic Acid and Low Molecular Weight Heparin for Enhanced Blood Managem...

Med Sci Monit In Press; DOI: 10.12659/MSM.944063  

Most Viewed Current Articles

14 Dec 2022 : Clinical Research   1,421,178

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

17 Jan 2024 : Review article   1,355,487

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research   690,090

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial   50,113

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750